A study to compare the safety and efficacy of durogesic [fentanyl] with sustained release morphine in patients with cancer pain transferring from weak to strong opioids.
Latest Information Update: 30 Mar 2020
Price :
$35 *
At a glance
- Drugs Fentanyl (Primary) ; Morphine
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 04 Aug 2009 Actual end date (Mar 2007) added as reported by ISRCTN: Current Controlled Trials.
- 04 Aug 2009 Actual initiation date (1 Jan 1997) added as reported by ISRCTN: Current Controlled Trials.
- 04 Aug 2009 Status changed from not stated to completed as reported by ISRCTN: Current Controlled Trials.